Immune checkpoint inhibitors for metastatic bladder cancer - Massari, Francesco; Di Nunno, Vincenzo; Cubelli, Marta; Santoni, Matteo; Fiorentino, Michelangelo; Montironi, Rodolfo; Cheng, Liang; Lopez-Beltran, Anto; Battelli, Nicola; Ardizzoni, Andrea (Cancer treatment reviews, 2018)
Keywords: Animals; Antibodies, Monoclonal - pharmacology; Atezolizumab; Avelumab; B7-H1 Antigen - antagonists & inhibitors; Combination therapy; Durvalumab; Humans; Immune-checkpoint inhibitors; Immunotherapy; Ipilimumab; Molecular Targeted Therapy; Nivolumab; Pembrolizumab; Urinary Bladder Neoplasms - drug therapy; Urinary Bladder Neoplasms - immunology; Urinary Bladder Neoplasms - metabolism; Urinary Bladder Neoplasms - secondary; Urothelial carcinoma; Pembrolizumab; Durvalumab; Nivolumab; Ipilimumab; Avelumab; Urothelial carcinoma; Combination therapy; Immune-checkpoint inhibitors; Atezolizumab